Company intelligence / Profile preview

Feetsee

Ownership: Private
Development stage: Commercial

Overview

Feetsee has developed and clinically validated an at-home contactless thermal imaging device that enables early detection of inflammation in the feet to prevent diabetic foot ulcers. The technology integrates high-resolution thermal/optical cameras with advanced ML algorithms, providing real-time alerts to patients and clinicians. Clinical trials have been completed validating its performance, and it is FDA registered as a Class I medical device in the US market. The product is available both for home use by patients and clinical use by healthcare providers.

Therapeutic areas: EndocrinologyRheumatology
Modalities: Digital health/medical device (thermal imaging, ML-based analysis)DiagnosticsMonitoring
Industry: Medical Imaging

Partnerships

Collaborates with academic institutions

Beyond the preview

Go deeper on Feetsee.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feetsee.

Explore the full profile